Enasidenib Mesylate
Brand name: Idhifa
Rank #438 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$18.1M
Total Cost
554
Total Claims
$18.1M
Total Cost
36
Prescribers
$33K
Cost per Claim
0
Beneficiaries
554
30-Day Fills
$503K
Avg Cost/Provider
15
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$18.1M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $18.1M total
🔎 Data Overview
At $32,710 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $503,372 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Enasidenib Mesylate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Travis Williams | Hematology-Oncology | Meridian, ID | 38 | $1.2M |
| 2 | Sara Bresser | Physician Assistant | Houston, TX | 31 | $1.0M |
| 3 | Yazan Madanat | Hematology-Oncology | Dallas, TX | 30 | $975K |
| 4 | Alexis Cruz-Chacon | Hematology-Oncology | San Juan, PR | 26 | $869K |
| 5 | Gregory Behbehani | Hematology-Oncology | Columbus, OH | 24 | $770K |
| 6 | Gabriela Hobbs | Hematology-Oncology | Boston, MA | 21 | $703K |
| 7 | Jenna Moran | Nurse Practitioner | Boston, MA | 22 | $689K |
| 8 | Aileen Go | Hematology-Oncology | Maywood, IL | 15 | $502K |
| 9 | Amer Zeidan | Medical Oncology | New Haven, CT | 15 | $464K |
| 10 | Ruthee-Lu Bayer | Medical Oncology | Lake Success, NY | 17 | $452K |
| 11 | Scott Letellier | Medical Oncology | Bellingham, WA | 13 | $450K |
| 12 | Courtney Dinardo | Hematology-Oncology | Houston, TX | 13 | $448K |
| 13 | Maureen Thyne | Physician Assistant | New York, NY | 14 | $443K |
| 14 | Samantha Salvatora | Physician Assistant | Houston, TX | 13 | $441K |
| 15 | Mark Sitarik | Hematology-Oncology | Boulder, CO | 13 | $439K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 435 | Elapegademase-Lvlr (Revcovi) | $19.0M | 52 |
| 436 | Methylprednisolone (Methylprednisolone) | $18.9M | 1,934,494 |
| 437 | Sacrosidase (Sucraid) | $18.5M | 1,517 |
| 438 | Enasidenib Mesylate (Idhifa) | $18.1M | 554 |
| 439 | Posaconazole (Posaconazole) | $18.0M | 7,163 |
| 440 | Metronidazole (Metronidazole) | $18.0M | 405,967 |
| 441 | Rufinamide (Rufinamide) | $18.0M | 8,793 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology